Advertisement

Picture Berlin Partner Bionnale the Annual Life Sciences Event 650x80px
Document › Details

Nemis Technologies AG. (2/3/22). "Press Release: Nemis Technologies AG Closes a CHF 7.75 Million Series A Funding Round". Dübendorf.

Organisation Organisation Nemis Technologies AG
Products Product food analysis (food testing)
  Product 2 venture capital
Index term Index term Nemis Technologies–SEVERAL: investment, 202202 financing round Series A CHF7.75m from institutional + private investors
Persons Person Muller, Arnaud (Nemis Technologies 202202 CEO + Co-Founder)
  Person 2 Meier, Roger (Versameb 201812 Board Chairman)
     


The investment will enable the Swiss Biotech Startup to further scale up its production, boost product development and pursue its ambitious internationalization strategy to meet increasing global demand.


Swiss Food & Nutrition Valley member, NEMIS Technologies Ltd. – ranked as one of the Top 15 Swiss Biotech Startups in 2021 – announced the closing of a CHF 7.75 million Series A financing round with the participation of both institutional and private investors this week.


The problem

Food borne pathogens like Listeria Monocytogenes, Salmonella, E. Coli and others can be found everywhere and are spreading rapidly throughout global food and supply chains. They make hundreds of thousands of consumers sick every year, and can even be fatal. Contamination by microorganisms also causes huge amounts of food waste. Food manufacturers and distributors are increasingly confronted with product recalls, which not only cause immense financial costs, but also major reputational damage to the companies concerned.


The solution

NEMIS specializes in fast, easy-to-use, affordable and reliable on-site pathogen detection solutions. The company will use the investment to scale up its production, accelerate its ongoing international expansion, boost product development and relocate to new laboratory and office facilities in Au, ZH, Switzerland.


Arnaud Muller, CEO of NEMIS, stated:

“Following the great care and dedication of our team over the past year to rapidly industrialize and scale our production, the capital raised will enable us to accelerate our expansion in Europe and overseas. We also have the means to accelerate the development of additional diagnostic test kits and methods to further improve our offering, strengthen our organization in a targeted manner and to reach profitable growth. This would not be possible without the great trust from our partners and investors, for which we are very grateful.”


Roger Meier, the Chairman of the Board, added:

“In just three years, NEMIS has transformed itself from an interesting start-up into a very dynamic and promising growth company with a value proposition that serves a rapidly growing need in an almost optimal way. We are very pleased that we were able to inspire different types of investors – from the extraordinary successful company leader and entrepreneur to the international highly specialized, renown Foodtech fund, who will accompany us on our further journey. With gratitude and confidence, we look forward to creating great benefit for our stakeholders.”


About NEMIS Technologies Ltd

NEMIS Technologies Ltd. (www.nemistech.com) founded in January 2018 by an experienced team of entrepreneurs, scientists and diagnostics, medical and food business professionals. Its patented core technology opens up a near-endless application space for the detection, identification, or monitoring of bacteria, parasites, viruses, or fungi. Unlike most other technologies, the company’s kits can be used anywhere by anyone, empowering food producers to take back control. By meeting several stringent requirements simultaneously, the young company is now on the verge of setting a new transformative industry standard. The power of mass testing closes the current environment control gaps and enables permanent process control in the food chain and allows for preventative elimination of contaminated sites to massively improve product safety.

   
Record changed: 2022-02-17

Advertisement

Picture [iito] Männer Ballett 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Bionnale the Annual Life Sciences Event 650x80px




» top